Literature DB >> 25713400

Early detection of nerve injury in transthyretin-related familial amyloid polyneuropathy.

Jasper M Morrow1, Mary M Reilly2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25713400      PMCID： PMC4408437          DOI： 10.1093/brain/awu396

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  8 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Authors:  R A C Hughes; P Bouche; D R Cornblath; E Evers; R D M Hadden; A Hahn; I Illa; C L Koski; J M Léger; E Nobile-Orazio; J Pollard; C Sommer; P Van den Bergh; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2006-04       Impact factor: 6.089

2.  Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR).

Authors:  H E Wilczek; M Larsson; B-G Ericzon
Journal:  Amyloid       Date:  2011-06       Impact factor: 7.141

Review 3.  FAP neuropathy and emerging treatments.

Authors:  David Adams; Marie Théaudin; Cecile Cauquil; Vincent Algalarrondo; Michel Slama
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

4.  Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.

Authors:  Teresa Coelho; Luis F Maia; Ana Martins da Silva; Marcia Waddington Cruz; Violaine Planté-Bordeneuve; Pierre Lozeron; Ole B Suhr; Josep M Campistol; Isabel Maria Conceição; Hartmut H-J Schmidt; Pedro Trigo; Jeffery W Kelly; Richard Labaudinière; Jason Chan; Jeff Packman; Amy Wilson; Donna R Grogan
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

5.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

6.  Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy.

Authors:  V Planté-Bordeneuve; T Lalu; M Misrahi; M M Reilly; D Adams; C Lacroix; G Said
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

7.  Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies.

Authors:  C D J Sinclair; J M Morrow; M A Miranda; I Davagnanam; P C Cowley; H Mehta; M G Hanna; M Koltzenburg; T A Yousry; M M Reilly; J S Thornton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-05-25       Impact factor: 10.154

8.  In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.

Authors:  Jennifer Kollmer; Ernst Hund; Benjamin Hornung; Ute Hegenbart; Stefan O Schönland; Christoph Kimmich; Arnt V Kristen; Jan Purrucker; Christoph Röcken; Sabine Heiland; Martin Bendszus; Mirko Pham
Journal:  Brain       Date:  2014-12-18       Impact factor: 13.501
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.